About Matthew Cheng
Form D filings for Kanvas Biosciences from 2023 to 2024 list Matthew Cheng as CEO and director.
Matthew Cheng first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Cheng in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Cheng works with at each company, as listed on that company's latest Form D.
Kanvas Biosciences, Inc. · Form D, Mar 18, 2024